F. Ammirati
Transcript
F. Ammirati
1. Asystolic Tilt Test and PM 2. Dual Chamber pacemaker with RDR-algorithm vs other possible algorithms Europace. 2012 Jul;14(7):1038-43. doi: 10.1093/europace/eur419. Epub 2012 Jan 13. Closed-loop cardiac pacing vs. conventional dual-chamber pacing with specialized Sensing and pacing algorithms for syncope prevention in patients with refractory vasovagal syncope: results of a long-term follow-up. Palmisano P1, Zaccaria M, Luzzi G, Nacci F, Anaclerio M, Favale S 41 patients (44% male, 53 ± 16 years) with recurrent, refractory VVS (26% with trauma) and a cardioinhibitory response to HUTT 25 patients received a dual-chamber CLS pacemaker (CLS group) 16 patients received a dual-chamber pacemaker with conventional algorithms for syncope prevention (conventional pacing group): 9 patients with Medtronic rate drop response algorithm 7 patients with Guidant-Boston Scientific sudden brady response algorithm. During the follow-up (mean 4.4 ± 3.0 years, interquartile range 2.2-7.4 years) one patient (4%) in the CLS group and six (38%) in the conventional pacing group had syncope recurrences (P= 0.016). retrospective analysis BIOSync TRIAL BENEFIT OF DUAL-CHAMBER PACING WITH CLOSED LOOP STIMULATION (CLS) IN TILT-INDUCED (TILT-POSITIVE) CARDIO-INHIBITORY REFLEX SYNCOPE. A RANDOMIZED DOUBLE-BLIND PARALLEL TRIAL Coordinating Clinical Investigator Dr. M. Brignole Co-Coordinating Clinical Ospedali del Tigullio Investigator Arrhythmologic Centre, Department of Cardiology Dr. M. Tomaino Via Don Bobbio, 25 16033 Lavagna (GE) - Italy Ospedale Centrale di Bolzano Department of Cardiologia Via Lorenz Böhler, 5 39100 Bolzano - Italy Steering Committee: M. Brignole, IT A. Aerts, Heerle, NE F. Ammirati, Roma, IT H. Burri, Geneva, CH J.C. Deharo, Marseille, FR M. Hamdan, Wisconsin, US A. Moya, Barcelona, ES M. Tomaino, Bolzano, IT 1. Asystolic Tilt Test and PM 2. Dual Chamber pacemaker with RDR-algorithm vs other possible algorithms BIOSync TRIAL BENEFIT OF DUAL-CHAMBER PACING WITH CLOSED LOOP STIMULATION (CLS) IN TILT-INDUCED (TILT-POSITIVE) CARDIO-INHIBITORY REFLEX SYNCOPE. A RANDOMIZED DOUBLE-BLIND PARALLEL TRIAL Coordinating Clinical Investigator Dr. M. Brignole Co-Coordinating Clinical Ospedali del Tigullio Investigator Arrhythmologic Centre, Department of Cardiology Dr. M. Tomaino Via Don Bobbio, 25 16033 Lavagna (GE) - Italy Ospedale Centrale di Bolzano Department of Cardiologia Via Lorenz Böhler, 5 39100 Bolzano - Italy Steering Committee: M. Brignole, IT A. Aerts, Heerle, NE F. Ammirati, Roma, IT H. Burri, Geneva, CH J.C. Deharo, Marseille, FR M. Hamdan, Wisconsin, US A. Moya, Barcelona, ES M. Tomaino, Bolzano, IT BIOSync TRIAL PERCHE ‘ NON IMPIANTARE IL PACEMAKER 1. Natura benigna della sincope riflessa neuromediata 2. Non ancora una decisa letteratura scientifica a favore del pacemaker 3. 25% di recidive sincopali a due anni nonostante il pacemaker 4. Terapie alternative meno aggressive, in classe I sec. linee guida ESC